J1300 – Injection, eculizumab, 10 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1300
- Long description
- Injection, eculizumab, 10 mg
- Short description
- Eculizumab injection
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2008
- Last change
- April 1, 2025 – No change
- Termination date
- March 31, 2025
Frequently asked questions
What is HCPCS code J1300?
J1300 is a HCPCS Level II code for injection, eculizumab, 10 mg. It was discontinued on March 31, 2025.
Does Medicare cover J1300?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1260 – Injection, dolasetron mesylate, 10 mg
- J1265 – Injection, dopamine hcl, 40 mg
- J1267 – Injection, doripenem, 10 mg
- J1270 – Injection, doxercalciferol, 1 mcg
- J1271 – Injection, doxycycline hyclate, 1 mg
- J1289 – Injection, narsoplimab-wuug, 1 mg
- J1290 – Injection, ecallantide, 1 mg
- J1299 – Injection, eculizumab, 2 mg
- J1301 – Injection, edaravone, 1 mg
- J1302 – Injection, sutimlimab-jome, 10 mg
- J1303 – Injection, ravulizumab-cwvz, 10 mg
- J1304 – Injection, tofersen, 1 mg
- J1305 – Injection, evinacumab-dgnb, 5mg
- J1306 – Injection, inclisiran, 1 mg
- J1307 – Injection, crovalimab-akkz, 10 mg
- J1308 – Injection, famotidine, 0.25 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.